Thermo Fisher Scientific Inc. announced the launch of two next-generation mass spectrometers, the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectrometer (MS) and the Thermo Scientific™ Orbitrap™ Excedion™ Pro mass spectrometer (MS). These instruments are designed to push the boundaries of scientific discovery, particularly in biopharma applications and omics research.
The Orbitrap Astral Zoom MS delivers unparalleled analytical performance and speed, engineered to drive breakthroughs in scientific research with 35% faster scan speeds, 40% higher throughput, and 50% expanded multiplexing capabilities. This allows research scientists to extract richer data from samples and accelerate discoveries in precision medicine and complex diseases.
The Orbitrap Excedion Pro MS builds on Orbitrap technology's sensitivity, resolution, and accuracy, offering enhanced performance to accelerate biological drug development. It is the first platform to combine next-generation Orbitrap hybrid mass spectrometry with alternative fragmentation technologies, providing a deeper understanding of biotherapeutics like monoclonal antibodies and accelerating treatment development across various medical fields.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.